Application of Jinfeng pill and preparation thereof in preparation of medicine for treating polycystic ovarian syndrome

By combining Jin Feng Wan with cyproterone acetate, the hypothalamic-pituitary gonadotropin function is regulated. Combined with traditional Chinese medicine to warm the kidneys, invigorate yang, and promote blood circulation, the treatment challenges of polycystic ovary syndrome are solved, and significant promotion of follicle development and protection of follicle reserve are achieved.

CN118987108APending Publication Date: 2024-11-22TONGYITANG PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410915100.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-09
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Current treatments for polycystic ovary syndrome (PCOS) suffer from problems such as significant trauma, unsatisfactory long-term effects, substantial side effects, and high recurrence rates, and there is a lack of effective drug treatment options.

Method used

By combining Jin Feng Wan and its preparations with cyproterone acetate, the gonadotropin-releasing hormone (GnRH) function of the hypothalamus-pituitary axis is regulated, the gene expression of GnRH is adjusted, and follicle development is promoted. Furthermore, the estrogen level is increased through the warming and invigorating effects of traditional Chinese medicine combinations such as Xianmao and Yimucao, which also promote blood circulation.

Benefits of technology

It significantly improved cyclophosphamide-induced serum hormone abnormalities in rats, promoted the recruitment of primordial follicles, reduced follicle inventory depletion, and provided long-term therapeutic effects.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses an application of Jinfeng pills and a preparation thereof in preparing a medicine for treating polycystic ovarian syndrome, and belongs to the technical field of medicines. A kidney-tonifying traditional Chinese medicine can release hormones and related neurotransmitters (such as noradrenaline, dopamine and the like) through gonadotrophin, and has a regulating effect on synthesis and release of the hormones and related neurotransmitters (such as noradrenaline, dopamine and the like); the gonad promoting function of hypothalamic pituitary is adjusted; the gene expression of hypothalamus pituitary gonadotropin, glandular pituitary follicle-stimulating hormone and luteinizing hormone can also be regulated at the transcriptional level; therefore, the kidney-tonifying traditional Chinese medicine can improve the estrogen level of an organism or has an estrogen-like effect and can promote follicle development, the Jinfeng pill preparation shows a good treatment effect in treatment of cyclophosphamide-induced premature ovarian insufficiency, the abnormal change of cyclophosphamide-induced rat serum hormones is remarkably improved, recruitment of primordial follicles is promoted, and the curative effect of the kidney-tonifying traditional Chinese medicine on early ovarian insufficiency induced by cyclophosphamide is improved. And the follicle inventory loss is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of medical technology, and in particular, relates to the application of Jinfeng Pills and preparations thereof in the preparation of medicines for treating polycystic ovary syndrome. Background Art

[0002] Polycystic Ovary Syndrome (PCOS) is a complex genetic heterogeneous disease characterized by hyperandrogenism (HA). Its clinical manifestations are diverse, such as irregular menstruation, infertility, hirsutism, acne, acanthosis nigricans, etc., and can cause a variety of short-term and long-term complications, such as pregnancy syndrome (spontaneous abortion, pregnancy-induced hypertension) metabolic syndrome (obesity, diabetes) and cardiovascular disease, tumors, etc. Its incidence rate is as high as 7-10%, and according to the diagnostic criteria formulated by the Rotterdam Conference in 2003, more patients are included in the category of PCOS, which makes PCOS a common endocrine and metabolic disorder in women of childbearing age.

[0003] At present, there is no ideal treatment for PCOS. Western medicine has measures such as ovarian wedge resection, laparoscopic ovarian puncture, drug ovulation induction, and drug anti-androgen. The surgery is traumatic and the long-term effect is not ideal, while the drug treatment effect is limited, has no positive preventive effect on the occurrence of long-term complications, and has large side effects. It cannot be taken for a long time and has a high recurrence rate after stopping the drug. Therefore, improvement and innovation in the treatment of polycystic ovary drugs is an issue that needs to be solved urgently. Summary of the invention

[0004] The purpose of the invention is to disclose the application of Jinfeng Pills and a preparation thereof in preparing a drug for treating polycystic ovary syndrome to meet the needs of clinical application.

[0005] Application of Jinfeng Pills in the preparation of drugs for treating polycystic ovary syndrome

[0006] Preferably, cyproterone acetate is mixed with Jinfeng Pills to form a preparation.

[0007] Preferably, the preparation is an oral preparation.

[0008] The present invention also discloses a drug for treating polycystic ovary syndrome. The drug is the above-mentioned cyproterone acetate. The cyproterone acetate raw material is subjected to ketal reaction, cyproterone hydrolysis reaction, acetyl reaction, epoxidation reaction, chlorination reaction and cyclization reaction to obtain the cyproterone acetate finished product.

[0009] Preferably, 280-320 parts of dichloromethane, 80-100 parts of ethylene glycol, 80-100 parts of triethyl orthoformate are drawn into the reactor, 130-170 parts of dehydrogenated products, 2-4 parts of p-toluenesulfonic acid are added, the reaction is carried out for 4-6 hours, triethylamine is added to neutralize the pH to 8, the dichloromethane is recovered by negative pressure concentration, 90-110 parts of methanol are added to dry once, the mixture is concentrated to a thick state, frozen and crystallized, centrifuged, and put into a drying equipment, the infrared heating tube is started, irradiated for 5 minutes, the speed of the motor 19 is controlled to 900-1100r / min, and the operation is continued for 10 minutes to obtain a ketal; the dehydrogenated product is 1,4,6-triene-3,20-dione-17a-hydroxy Progesterone, add 450-550 parts of DMF, 120-160 parts of ketal, 80-90 parts of trimethyl sulfonium bromide into a reaction kettle, stir evenly, add 27 parts of caustic soda at 42-45°C, react for 3 hours after addition, add 20% dilute sulfuric acid to adjust the pH value to 2, hydrolyze for 2 hours, pump the material into a hydrolysis kettle for hydrolysis, centrifuge, wash with water until neutral, put into a drying equipment, start the infrared heating tube, irradiate for 8 minutes, control the motor speed to 800-1000r / min, continue to run for 10 minutes, and obtain cyclopropane hydrolyzate, pump 400 parts of chloroform and 70 parts of acetic anhydride into the reaction kettle, add 10 0 parts of cyclopropane hydrolyzate and 2 parts of p-toluenesulfonic acid, heat to 58-60℃ and reflux for 5-6 hours, cool to 20-30℃, add 180 parts of water for washing, stand to separate chloroform, add 100 parts of ethyl acetate to dry once, freeze to 0-2℃ for crystallization, centrifuge, put into drying equipment, start infrared heating tube, irradiate for 5 minutes, control motor 19 speed to 1000-1300r / min, continue to run for 15 minutes, get acetylated product, draw 1300 parts of ethyl acetate and 130 parts of hydrogen peroxide into the peracid reactor, add 240 parts of phthalic anhydride, react at 20-30℃ for 8 hours, add 100 parts of water for washing, stand to separate the lower layer The water layer forms peracid; ethyl acetate and 100 parts of acetylated substances are added to the epoxy reaction kettle, the temperature is controlled at 25-27°C, peracid is added, the reaction is continued for 5 hours after addition, water is added, stirred, allowed to stand, the lower water layer is separated, the acetylated ester layer is concentrated to dryness under negative pressure at a temperature of <60°C, the ethyl acetate is recovered and reused, 450 parts of glacial acetic acid are drawn into the epoxy concentration kettle, and after dissolution, it is drawn into the chlorination reaction kettle, and then 240 parts of acetic anhydride are drawn, 240 parts of anhydrous calcium chloride are added, hydrochloric acid is drawn to the high-level tank, the temperature is controlled at 0-5°C, 240 parts of hydrochloric acid are added dropwise, the temperature is controlled at 27-29°C, the reaction is continued for 10 hours, the material is drawn into the water separation kettle for water separation, centrifuged and washed with water until neutral, and dried to obtain a crude chloride product;180 parts of anhydrous methanol and 430 parts of dichloromethane were added to the refining reactor, the dichloromethane was concentrated under negative pressure at a temperature of 50°C, the product was frozen and crystallized at 0-5°C, centrifuged, and put into a drying device, the infrared heating tube was started, irradiated for 10 minutes, the motor speed was controlled to be 1000-1300r / min, and it was continuously operated for 12 minutes to obtain chloride, 140 parts of DMF and 110 parts of methanol were drawn into the cyclization reactor, 110 parts of chloride and 40 parts of sodium acetate were added, the temperature was raised to 50-55°C, and the reaction was reacted for 5 hours, and the product was precipitated into a hydrolysis reactor, stirred, centrifuged, dried, washed with water, and dried to obtain a crude cyclized product; 1000 parts of ethanol were drawn into the decolorization reactor, 100 parts of cyclohexane were added, and 100 parts of cyclohexane were added. The crude product of the compound is heated to 75°C to dissolve, 10 parts of activated carbon are added for decolorization, filtered to a concentration kettle, and concentrated to 1 times the volume of the mother liquor under negative pressure at a temperature of 70°C; the temperature is reduced to 0-5°C for crystallization, centrifuged, and dried to obtain the crude product of cyproterone acetate; 900 parts of ethanol are drawn into the decolorization reaction kettle, the crude product of cyproterone acetate is added, the temperature is increased to 75°C for dissolution, 10 parts of activated carbon are added for decolorization, filtered to a concentration kettle, the temperature is controlled to 70°C for negative pressure to concentrate to 1 times the volume of the mother liquor, the temperature is reduced to 0-5°C for crystallization, centrifuged, dried, and put into a drying equipment, the infrared heating tube is started, and the irradiation is carried out for 10 minutes. The speed of the motor 19 is controlled to be 1400-1800r / min, and it is continuously operated for 20 minutes to obtain the finished product of cyproterone acetate. ;

[0010] The invention also discloses a Jinfeng pill, which is composed of nine Chinese medicinal materials including curculigo, motherwort, donkey-hide gelatin, polygonum multiflorum, cinnamon bark, Ligustrum lucidum fruit, pilose antler and ginseng.

[0011] Preferably, curculigo, motherwort, donkey-hide gelatin, polygonum multiflorum, cinnamon bark, Ligustrum lucidum, pilose antler and ginseng are formed into pills through the steps of crushing, filtering, refining honey, mixing, strip making and pill making.

[0012] Preferably, epimedium, curculigo, motherwort, donkey-hide gelatin, polygonum multiflorum, cinnamon, glossy privet, pilose antler and ginseng are ground into powder, the powder is sieved through a sieve to filter out impurities, honey is poured into a pot and boiled over low heat, and a spoon is used to stir continuously until the honey keeps bubbling and the color changes to brown-yellow, and then poured into the powder, the honey and powder are fully mixed, and repeatedly kneaded into a ball, the ball is placed on the surface of a mold and repeatedly pushed and pressed with a board to make the ball into strips, the strips are placed in the pill groove of the pill-making mold and the mold cover is pushed to make the strips into pills.

[0013] Preferably, the surface of the bar-making mold is brushed with sesame oil.

[0014] Compared with the prior art, the present invention has the following beneficial effects:

[0015] Kidney-tonifying Chinese medicine can adjust the gonadotropin function of the hypothalamus-pituitary gland by regulating the synthesis and release of gonadotropin-releasing hormone and its related neurotransmitters (such as norepinephrine, dopamine, etc.); it can also regulate the gene expression of hypothalamic-pituitary gonadotropin, adenohypophysis follicle-stimulating hormone, and luteinizing hormone at the transcriptional level; therefore, kidney-tonifying Chinese medicine can increase the body's estrogen level or estrogen-like effects, which can promote follicle development. Jinfeng Pill preparations have shown good therapeutic effects in the treatment of cyclophosphamide-induced premature ovarian insufficiency, significantly improving the abnormal changes in serum hormones induced by cyclophosphamide in rats, promoting the recruitment of primordial follicles, and reducing the depletion of follicle stocks. DETAILED DESCRIPTION

[0016] The embodiments of the present invention disclose the use of Jinfeng Pills and their preparations in the preparation of drugs for treating polycystic ovary syndrome. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters to achieve it. It is particularly important to point out that all similar substitutions and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The application of the present invention has been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the application described herein without departing from the content, spirit and scope of the present invention to realize and apply the technology of the present invention.

[0017] For a further understanding of the present invention, the present invention is described in detail below in conjunction with embodiments.

[0018] Jinfeng Pills are composed of nine Chinese herbs, including Epimedium, Curculigo, Leonurus, Donkey-hide Gelatin, Polygonum Multiflorum, Cinnamon, Ligustrum Lucidum, Deer Antler, and Ginseng. Jinfeng Pills warm the kidney and benefit Yang, activate blood circulation, and are used to treat chills, scanty menstruation, delayed menstruation, heavy vaginal discharge, and cold dysmenorrhea caused by kidney Yang deficiency.

[0019] Among them, deer antler and epimedium are the main medicines, which can replenish essence and marrow, nourish the kidney and strengthen yang; ginseng, Polygonum multiflorum, Ligustrum lucidum and donkey-hide gelatin are the assistant medicines, which can nourish blood and produce body fluid, calm the mind and improve intelligence, strengthen the waist and kidney, nourish yin and moisten dryness; motherwort, cinnamon and curculigo are the adjuvant medicines, which can warm the meridians and uterus, dispel cold and eliminate numbness, nourish blood and regulate menstruation; honey is the messenger medicine, which can replenish the middle and benefit qi, nourish the five internal organs and harmonize all the medicines.

[0020] In this embodiment, the drug for treating polycystic ovary syndrome is compound cyproterone acetate, and the preparation of compound cyproterone acetate includes the following preparation steps:

[0021] Ketal reaction: 280-320 parts of dichloromethane, 80-100 parts of ethylene glycol, 80-100 parts of triethyl orthoformate are drawn into the reaction kettle, 130-170 parts of dehydrogenated product and 2-4 parts of p-toluenesulfonic acid are added, and the reaction is carried out for 4-6 hours, triethylamine is added to neutralize the pH to 8, and the dichloromethane is recovered by negative pressure concentration, and 90-110 parts of methanol are added to dry it once, and the mixture is concentrated to a thick state, frozen and crystallized, centrifuged, and put into a drying equipment, and the infrared heating tube is started, and the irradiation is carried out for 5 minutes, and the speed of the motor 19 is controlled to be 900-1100r / min, and the operation is continued for 10 minutes to obtain the ketal; the dehydrogenated product is 1,4,6-triene-3,20-dione-17a-hydroxyprogesterone;

[0022] Cyclopropane hydrolysis reaction: add 450-550 parts of DMF, 120-160 parts of ketal, 80-90 parts of trimethyl sulfonium bromide into a reactor, stir evenly, add 27 parts of caustic soda at 42-45°C, react for 3 hours, add 20% by mass concentration of dilute sulfuric acid to adjust the pH value to 2, hydrolyze for 2 hours, pump the material into a hydrolysis kettle for hydrolysis, centrifuge, wash with water until neutral, put into a drying equipment, start the infrared heating tube, irradiate for 8 minutes, control the motor speed to 800-1000r / min, and continue to run for 10 minutes to obtain cyclopropane hydrolyzate;

[0023] Acetylation: 400 parts of chloroform and 70 parts of acetic anhydride are drawn into the reaction kettle, 100 parts of cyclopropane hydrolyzate and 2 parts of p-toluenesulfonic acid are added, the temperature is raised to 58-60°C for reflux reaction for 5-6 hours, the temperature is lowered to 20-30°C, 180 parts of water are added for washing, the chloroform is separated by standing, 100 parts of ethyl acetate are added to dry once, the reaction is frozen to 0-2°C for crystallization, centrifuged, and put into the drying equipment, the infrared heating tube is started, and the irradiation is carried out for 5 minutes. The speed of the motor 19 is controlled to be 1000-1300r / min, and the operation is continued for 15 minutes to obtain the acetylated product;

[0024] Epoxy reaction: 1300 parts of ethyl acetate and 130 parts of hydrogen peroxide are drawn into the peracid reaction kettle, and 240 parts of phthalic anhydride are added, and the reaction is carried out at 20-30°C for 8 hours, and 100 parts of water are added for washing, and the lower water layer is separated to form peracid; ethyl acetate and 100 parts of acetylated products are added to the epoxy reaction kettle, and the temperature is controlled at 25-27°C, and the peracid is added, and the reaction is carried out for 5 hours after the addition is completed, and water is added, stirred, and the lower water layer is separated. The acetylated ester layer is concentrated to dryness under negative pressure at a temperature of <60°C, and the ethyl acetate is recovered and reused;

[0025] Chlorination reaction: 450 parts of glacial acetic acid are pumped into the epoxy concentration kettle, and after dissolving, they are pumped into the chlorination reaction kettle, and then 240 parts of acetic anhydride are pumped into it, 240 parts of anhydrous calcium chloride are added, and hydrochloric acid is pumped into the high-level tank, the temperature is controlled at 0-5°C, 240 parts of hydrochloric acid are added dropwise, and the temperature is controlled at 27-29°C for reaction for 10 hours after addition, and the material is pumped into the water separation kettle for water separation, centrifugal washing to neutrality, and drying to obtain a crude chloride product; 180 parts of anhydrous methanol and 430 parts of dichloromethane are added into the refining reaction kettle, and the dichloromethane is concentrated under negative pressure at a temperature of 50°C, and the dichloromethane is frozen and crystallized at 0-5°C, centrifuged, and put into the drying equipment, and the infrared heating tube is started, and irradiated for 10 minutes, and the motor speed is controlled to be 1000-1300r / min, and it is continuously operated for 12 minutes to obtain chloride;

[0026] Cyclization reaction: 140 parts of DMF and 110 parts of methanol were drawn into the cyclization reaction kettle, 110 parts of chloride and 40 parts of sodium acetate were added, the temperature was raised to 50-55°C for reaction for 5 hours, and the mixture was precipitated into the precipitation reaction kettle, stirred, centrifuged, dried, washed with water, and dried to obtain a crude cyclized product; 1000 parts of ethanol were drawn into the decolorization kettle, 100 parts of the crude cyclized product were added, the temperature was raised to 75°C to dissolve, 10 parts of activated carbon were added for decolorization, the mixture was filtered into the concentration kettle, the temperature was controlled at 70°C and the negative pressure was concentrated to 1 times the volume of the mother liquor; the mixture was reduced to 0-5°C for precipitation. crystallization, centrifugation, and drying to obtain a crude cyproterone acetate; 900 parts of ethanol are drawn into the decolorization reaction kettle, the crude cyproterone acetate is added, the temperature is raised to 75°C to dissolve, 10 parts of activated carbon are added for decolorization, and the mixture is filtered to a concentration kettle, the temperature is controlled at 70°C and the negative pressure is concentrated to 1 times the volume of the mother liquor, the temperature is reduced to 0-5°C for crystallization, centrifugation, drying, and the mixture is put into a drying equipment, the infrared heating tube is started, and the irradiation is carried out for 10 minutes, the speed of the motor 19 is controlled to be 1400-1800r / min, and the operation is continued for 20 minutes to obtain a finished cyproterone acetate.

[0027] The preparation method of Jinfeng Pills preparation comprises the following steps:

[0028] Crushing: crush epimedium, curculigo, motherwort, donkey-hide gelatin, polygonum multiflorum, cinnamon bark, Ligustrum lucidum, deer antler and ginseng into powder;

[0029] Filtering, passing the powder through a sieve to filter out impurities;

[0030] Refining honey: Pour honey into a pot and simmer over low heat, stirring constantly with a spoon until the honey keeps bubbling and the color turns brown-yellow, then pour it into the powder;

[0031] Mixing: Mix the honey and powder thoroughly; knead repeatedly into a ball;

[0032] Making strips: Brush the surface of the strip-making mold with sesame oil, place the medicine ball on the mold surface and use a board to push and press repeatedly to make the medicine ball into strips;

[0033] Pill making: Place the medicine strip in the pill slot of the pill making mold and push the mold cover to make the medicine strip into pills.

[0034] Cyproterone acetate is added into the powder of the raw material of Jinfeng Pills, and then the cyproterone acetate and Jinfeng Pills are mixed through the steps of mixing, strip making and pill making.

[0035] Rat modeling:

[0036] Rats with regular estrous cycles were selected and given the emergency contraceptive drug levonorgestrel by oral gavage to establish the model. The model was established at a fixed time every morning (8:30-10:30) for 28 consecutive days. The ovarian index was checked to determine whether the model was successful.

[0037] Efficacy trial of Jinfeng Pills in treating levonorgestrel-induced ovarian damage:

[0038] From the 8th day (D8) of the experiment, rats in each group were treated with solvent or Jinfeng Pills, among which the low-dose Jinfeng Pills group was given 160 mg / kg Jinfeng Pills, the high-dose Jinfeng Pills group was given 320 mg / kg Jinfeng Pills, and the solvent control and model control groups continued to be given an equal volume of solvent (0.5% CMC-Na). The drug administration volume was 0.5 ml / 100 g. The ovaries were taken, weighed, the organ coefficients were calculated, and the ovaries were pathologically examined; blood was taken to determine the serum concentrations of FSH, LH, AMH, E2 and P4.

[0039] Studies have shown that kidney-tonifying Chinese medicine can adjust the gonadotropin function of the hypothalamus-pituitary gland by regulating the synthesis and release of gonadotropin-releasing hormone (GnRH) and its related neurotransmitters (such as norepinephrine, dopamine, etc.); it can also regulate the gene expression of hypothalamic-pituitary gonadotropin (GnRH), pituitary follicle-stimulating hormone (FSH), and luteinizing hormone (LH) at the transcriptional level; therefore, kidney-tonifying Chinese medicine can increase the body's estrogen level or have estrogen-like effects, which can promote follicle development.

[0040] In summary, the study found that Jinfeng Pills showed good therapeutic effects in the treatment of cyclophosphamide-induced premature ovarian insufficiency, significantly improved the abnormal changes of cyclophosphamide-induced serum hormones in rats, promoted the recruitment of primordial follicles, and reduced the depletion of follicle stocks.

[0041] The above content is a further detailed description of the present invention in combination with specific implementation methods. It cannot be determined that the specific implementation of the present invention is limited to these descriptions. For ordinary technicians in the technical field to which the present invention belongs, several simple deductions or substitutions can be made without departing from the concept of the present invention, which should be regarded as belonging to the scope of protection determined by the claims submitted for the present invention.

Claims

1. Application of Jinfeng Pills in the preparation of drugs for the treatment of polycystic ovary syndrome.

2. The use of the Jinfeng Pill preparation according to claim 1 in the preparation of a drug for treating polycystic ovary syndrome, characterized in that: Cyproterone acetate is mixed with Jinfeng pills to form a preparation.

3. The use of the Jinfeng Pill preparation according to claim 2 in the preparation of a drug for treating polycystic ovary syndrome, characterized in that: The preparation is an oral preparation.

4. A drug for treating polycystic ovary syndrome, the drug being the cyproterone acetate of claim 2, characterized in that: The cyproterone acetate raw material is subjected to ketal reaction, cyproterone hydrolysis reaction, acetylation reaction, epoxidation reaction, chlorination reaction and cyclization reaction to obtain the cyproterone acetate finished product.

5. The drug for treating polycystic ovary syndrome according to claim 4, characterized in that: 280-320 parts of dichloromethane, 80-100 parts of ethylene glycol, 80-100 parts of triethyl orthoformate are drawn into the reaction kettle, 130-170 parts of dehydrogenated products and 2-4 parts of p-toluenesulfonic acid are added, the reaction is carried out for 4-6 hours, triethylamine is added to neutralize the pH to 8, the dichloromethane is recovered by negative pressure concentration, 90-110 parts of methanol are added to dry once, the mixture is concentrated to a thick state, frozen and crystallized, centrifuged, and put into a drying equipment, the infrared heating tube is started, the mixture is irradiated for 5 minutes, the speed of the motor 19 is controlled to be 900-1100 r / min, and the operation is continued for 10 minutes to obtain a ketal; the dehydrogenated product is 1,4,6-triene-3,20-dione-17a-hydroxyprogesterone , add 450-550 parts of DMF, 120-160 parts of acetal, 80-90 parts of trimethyl sulfonium bromide into the reactor, stir evenly, add 27 parts of caustic soda at 42-45°C, react for 3 hours, add 20% dilute sulfuric acid to adjust the pH to 2, hydrolyze for 2 hours, pump the material into the hydrolysis kettle for hydrolysis, centrifuge, wash with water until neutral, put into the drying equipment, start the infrared heating tube, irradiate for 8 minutes, control the motor speed to 800-1000r / min, continue to run for 10 minutes, and get cyclopropane hydrolyzate, pump 400 parts of chloroform and 70 parts of acetic anhydride into the reactor, add 100 parts Cyclopropane hydrolyzate and 2 parts of p-toluenesulfonic acid are heated to 58-60°C for reflux reaction for 5-6 hours, then cooled to 20-30°C, 180 parts of water are added for washing, chloroform is separated by standing, 100 parts of ethyl acetate are added for drying once, and crystallization is separated by centrifugation. The mixture is put into a drying device, and the infrared heating tube is started for 5 minutes. The speed of the motor 19 is controlled to be 1000-1300r / min and the operation is continued for 15 minutes to obtain an acetylated product. 1300 parts of ethyl acetate and 130 parts of hydrogen peroxide are drawn into the peracid reactor, and 240 parts of phthalic anhydride are added. The mixture is reacted at 20-30°C for 8 hours, 100 parts of water are added for washing, and the lower layer of water is separated by standing. layer to form peracid; add ethyl acetate and 100 parts of acetylated product to the epoxy reaction kettle, control the temperature at 25-27°C, add peracid, react for 5 hours after adding, add water, stir, stand, separate the lower water layer, control the temperature of the ethyl acetate layer to <60°C and concentrate to dryness under negative pressure, recover the ethyl acetate and reuse it, draw 450 parts of glacial acetic acid into the epoxy concentration kettle, draw it into the chlorination reaction kettle after dissolving, then draw 240 parts of acetic anhydride, add 240 parts of anhydrous calcium chloride, draw hydrochloric acid to the high-level tank, control the temperature at 0-5°C, add 240 parts of hydrochloric acid dropwise, control the temperature at 27-29°C and react for 10 hours after adding, draw the material to the water separation kettle for water separation, centrifuge and wash until neutral, and dry to obtain a crude chloride product;180 parts of anhydrous methanol and 430 parts of dichloromethane were added to the refining reactor, the dichloromethane was concentrated under negative pressure at a temperature of 50°C, the product was frozen and crystallized at 0-5°C, centrifuged, and put into a drying device, the infrared heating tube was started, irradiated for 10 minutes, the motor speed was controlled to be 1000-1300r / min, and it was continuously operated for 12 minutes to obtain chloride, 140 parts of DMF and 110 parts of methanol were drawn into the cyclization reactor, 110 parts of chloride and 40 parts of sodium acetate were added, the temperature was raised to 50-55°C, and the reaction was reacted for 5 hours, and the product was precipitated into a hydrolysis reactor, stirred, centrifuged, dried, washed with water, and dried to obtain a crude cyclized product; 1000 parts of ethanol were drawn into the decolorization reactor, 100 parts of cyclohexane were added, and 100 parts of cyclohexane were added. The crude product of the compound is heated to 75°C to dissolve, 10 parts of activated carbon are added for decolorization, filtered to a concentration kettle, and concentrated to 1 times the volume of the mother liquor under negative pressure at a temperature of 70°C; the temperature is reduced to 0-5°C for crystallization, centrifuged, and dried to obtain the crude product of cyproterone acetate; 900 parts of ethanol are drawn into the decolorization reaction kettle, the crude product of cyproterone acetate is added, the temperature is increased to 75°C for dissolution, 10 parts of activated carbon are added for decolorization, filtered to a concentration kettle, the temperature is controlled to 70°C for negative pressure to concentrate to 1 times the volume of the mother liquor, the temperature is reduced to 0-5°C for crystallization, centrifuged, dried, and put into a drying equipment, the infrared heating tube is started, and the irradiation is carried out for 10 minutes. The speed of the motor 19 is controlled to be 1400-1800r / min, and it is continuously operated for 20 minutes to obtain the finished product of cyproterone acetate. ; 6. The Jinfeng Pill according to claim 1, characterized in that: It is composed of nine Chinese medicinal herbs, including Curculigo, Motherwort, donkey-hide gelatin, Polygonum multiflorum, cinnamon, Ligustrum lucidum, deer antler, and ginseng.

7. The Jinfeng Pill according to claim 6, characterized in that: Curculigo, Leonurus japonicus, donkey hide gelatin, Polygonum multiflorum, cinnamon bark, Ligustrum lucidum fruit, pilose antler and ginseng are formed into pills through the processes of crushing, filtering, refining honey, mixing, making into strips and pilling.

8. The Jinfeng Pill according to claim 6, characterized in that: Grind epimedium, curculigo, motherwort, donkey-hide gelatin, polygonum multiflorum, cinnamon, glossy privet fruit, deer antler and ginseng into powder, sieve the powder to filter out impurities, pour honey into a pot and simmer over low heat, stirring constantly with a spoon until the honey keeps bubbling and the color turns brown, then pour it into the powder, mix the honey and powder thoroughly, knead them repeatedly into a ball, place the ball on the surface of the mold and use a board to push and press repeatedly to make the ball into strips, place the strips in the pill slot of the pill-making mold and push the mold cover to make the strips into pills.

9. The Jinfeng Pill according to claim 8, characterized in that: Brush the surface of the strip making mold with sesame oil.